P
Pilar Prados
Researcher at Autonomous University of Madrid
Publications - 83
Citations - 3130
Pilar Prados is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Bicyclic molecule & Hydrogen bond. The author has an hindex of 29, co-authored 83 publications receiving 3048 citations. Previous affiliations of Pilar Prados include University of Maryland, College Park.
Papers
More filters
Journal ArticleDOI
Carbon-13 NMR chemical shifts. A single rule to determine the conformation of calix[4]arenes
TL;DR: The conformations of calix [4] arenes can be deduced from the 13 C NMR chemical shift of the methylene groups connecting each pair of aromatic rings.
Journal ArticleDOI
A receptor for the enantioselective recognition of phenylalanine and tryptophan under neutral conditions
Journal ArticleDOI
Using small molecules to facilitate exchange of bicarbonate and chloride anions across liposomal membranes
Jeffery T. Davis,Philip A. Gale,Oluyomi A. Okunola,Pilar Prados,Jose Carlos Iglesias-Sánchez,Tomás Torroba,Roberto Quesada +6 more
TL;DR: The results suggest that small molecules may also be able to regulate the concentration of these anions in biological systems.
Journal ArticleDOI
Conformational control of transmembrane Cl(-) transport.
Paul V. Santacroce,Jeffery T. Davis,Mark E. Light,Philip A. Gale,Jose Carlos Iglesias-Sánchez,Pilar Prados,Roberto Quesada +6 more
TL;DR: Preorganization of the isophthalamide cleft in N,N‘-dibutyl-4,6-dihydroxyisophthalamia results in an enhanced anion receptor that displays significant chloride transport activity into EYPC liposomes.
Journal ArticleDOI
Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria.
Jimena Fernández-Carneado,Michiel Luc Maria Van Gool,Vera Martos,Susanna Castel,Pilar Prados,Javier de Mendoza,Ernest Giralt +6 more
TL;DR: A new family of tetraguanidinium cell penetrating vectors efficiently internalized in human tumor cells is reported, likely vehicles for the targeted delivery of anticancer drugs to mitochondria.